{
 "context": "The following article called 'Dow, S&P 500 fall on oil-sector weakness' was published on 2015-07-31. The body of the article is as follows:\n    \nView Photo \n\nWeakness in petroleum-linked equities weighed down the Dow and the S&P 500 Friday following poor earnings from ExxonMobil and Chevron (Swiss: CVX.SW - news ) and a drop in oil prices. \nAt the closing bell, the Dow Jones Industrial Average stood at 17,695.11, down 49.87 points (0.28 percent). \nThe broad-based S&P 500 fell 3.83 (0.18 percent) to 2,104.80, while the tech-rich Nasdaq Composite Index added a scant 1.87 (0.04 percent) at 5,130.65. \nDow component ExxonMobil shed 4.6 percent after reporting net income fell by 52.3 percent year-over-year to $4.2 billion in the second quarter. Chevron lost 4.9 percent as it reported about a 90 percent drop in profits to just $571 million. \nBut the pain to petroleum-oriented equities did not end there. Drilling company Nabors Industries (NYSE: NBR - news ) lost 1.8 percent and producer Marathon Oil shed 3.8 percent after US oil prices dived almost 3.0 percent to close at $47.52 a barrel.\n\n    The day before the article was published, the stock price of Akari Therapeutics Plc was 5.800000190734863 and the day after the article was published, the stock price of Akari Therapeutics Plc was ",
 "expected": "5.400000095367432",
 "date": "2015-07-31",
 "ticker": "AKTX",
 "company": "Akari Therapeutics Plc"
}